Medication info
Rabeprazole Sodium 20 mg Tablets

Rabeprazole Sodium 20 mg Tablets

Prescription medicationTabletOral
Ingredient · strength
Rabeprazole Sodium›20mg / 1 tablet
Manufacturer / importer
Independent Bio Pharmaceutical Co., Ltd.
Appearance
Pale yellow round enteric coated tablets
Packaging
28 tablets (14 tablets / PTP*2)
Approval status
Active

MFDS item code 201905356 · Approved 2019.07.29

Summary

Main use
Treatment of gastroesophageal reflux disease, peptic ulcers (including use in combination for eradication therapy), and Zollinger-Ellison syndrome
Who takes it
Adults · Children
Adult dose
Gastric ulcer, duodenal ulcer: The usual adult dose is 10 mg of rabeprazole sodium orally once daily. Depending on symptoms, 20 mg may be administered orally once daily. Treatment is usually given for up to 8 weeks for gastric ulcer and up to 6 weeks for duodenal ulcer. Erosive or ulcerative gastroesophageal reflux disease: Administer 10 mg or 20 mg once daily for 4 ∼ 8 weeks. If the condition has not healed after 8 weeks of treatment with a proton pump inhibitor (PPI, proton pump inhibitor), 10 mg or 20 mg may be administered orally twice daily for an additional 8 weeks. However, the 20 mg twice-daily dose is for patients with confirmed severe mucosal damage only. Symptom relief for gastroesophageal reflux disease: Administer 10 mg once daily. If symptoms are not controlled after 4 weeks of treatment, further evaluation is required. After symptoms resolve, subsequent symptoms may be controlled, as needed, using on-demand therapy with 10 mg once daily. Long-term maintenance treatment of gastroesophageal reflux disease: Administer 10 mg or 20 mg orally once daily, depending on the patient. Helicobacter pylori eradication: Patients infected with Helicobacter pylori should receive eradication therapy. Concomitant administration of this medicine 20 mg, clarithromycin 500 mg, and amoxicillin 1 g twice daily for 7 days is recommended. Zollinger-Ellison syndrome: The recommended initial dose for adults is 60 mg once daily. The dose may be adjusted up to 120 mg/day according to each patient's needs. Doses up to 100 mg may be administered once daily, while the 120 mg dose should be divided into 60 mg twice daily. Patients with Zollinger-Ellison syndrome have been treated with this medicine for up to 1 year. ○ Patients with hepatic impairment Adverse reactions of hepatic encephalopathy have been reported in patients with cirrhosis. Therefore, administer with caution. ○ Older adults Administer with caution, as hepatic function is often impaired.
Child dose
Safety in children has not been established.

Ingredients

Manufacturer
Independent Bio Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of gastroesophageal reflux disease, peptic ulcers (including use in combination for eradication therapy), and Zollinger-Ellison syndrome

  • Gastric ulcer
  • duodenal ulcer
  • erosive gastroesophageal reflux disease
  • ulcerative gastroesophageal reflux disease
  • symptoms of gastroesophageal reflux disease
  • digestive ulcers
  • Zollinger-Ellison syndrome
View approved original text

This medication is primarily used to treat gastric and duodenal ulcers. It also relieves symptoms of erosive or ulcerative gastroesophageal reflux disease and is effective for long-term maintenance therapy of this condition. It is used in combination with antibiotics to treat patients with digestive ulcers infected by Helicobacter pylori. It is also used in patients with Zollinger-Ellison syndrome to control excessive gastric acid secretion. This medication helps improve symptoms of various digestive-related ulcers and esophageal diseases.

How to take

Adult dose

Gastric ulcer, duodenal ulcer: The usual adult dose is 10 mg of rabeprazole sodium orally once daily. Depending on symptoms, 20 mg may be administered orally once daily. Treatment is usually given for up to 8 weeks for gastric ulcer and up to 6 weeks for duodenal ulcer. Erosive or ulcerative gastroesophageal reflux disease: Administer 10 mg or 20 mg once daily for 4 ∼ 8 weeks. If the condition has not healed after 8 weeks of treatment with a proton pump inhibitor (PPI, proton pump inhibitor), 10 mg or 20 mg may be administered orally twice daily for an additional 8 weeks. However, the 20 mg twice-daily dose is for patients with confirmed severe mucosal damage only. Symptom relief for gastroesophageal reflux disease: Administer 10 mg once daily. If symptoms are not controlled after 4 weeks of treatment, further evaluation is required. After symptoms resolve, subsequent symptoms may be controlled, as needed, using on-demand therapy with 10 mg once daily. Long-term maintenance treatment of gastroesophageal reflux disease: Administer 10 mg or 20 mg orally once daily, depending on the patient. Helicobacter pylori eradication: Patients infected with Helicobacter pylori should receive eradication therapy. Concomitant administration of this medicine 20 mg, clarithromycin 500 mg, and amoxicillin 1 g twice daily for 7 days is recommended. Zollinger-Ellison syndrome: The recommended initial dose for adults is 60 mg once daily. The dose may be adjusted up to 120 mg/day according to each patient's needs. Doses up to 100 mg may be administered once daily, while the 120 mg dose should be divided into 60 mg twice daily. Patients with Zollinger-Ellison syndrome have been treated with this medicine for up to 1 year. ○ Patients with hepatic impairment Adverse reactions of hepatic encephalopathy have been reported in patients with cirrhosis. Therefore, administer with caution. ○ Older adults Administer with caution, as hepatic function is often impaired.

Child dose

Safety in children has not been established.

Precautions

This medication should not be used in patients with certain allergic reactions. For example, it should not be administered to those with hypersensitivity to this medication or its components, or to benzimidazole derivatives. Additionally, caution is needed when using this medication in patients allergic to penicillin or macrolide antibiotics, especially in combination therapy with antibiotics for the eradication of Helicobacter pylori. It should not be used by pregnant or breastfeeding women as it may affect the fetus or newborn. Patients with decreased liver function, the elderly, and those with a history of drug allergies should use this medication with caution. Allergic reactions such as skin rash or itching may occur; if such symptoms arise, stop taking the medication immediately and consult a doctor. Regular blood tests may be necessary as changes in red blood cells, white blood cells, and platelet counts can occur. Liver function abnormalities may also occur; hence, regular liver function tests are advisable. Cardiac symptoms, changes in blood pressure, headaches, and dizziness have also been reported, so attention should be given if these symptoms occur. Digestive symptoms may include diarrhea, abdominal pain, and nausea, and any abnormal symptoms should be reported to a doctor. It may affect the mental and neurological system, leading to anxiety, insomnia, drowsiness, and depression, so caution is needed. Respiratory symptoms, muscle pain, joint pain, and skin adverse reactions have also been reported, so consultation with healthcare personnel is recommended if symptoms arise. Long-term use of this medication may increase the risk of osteoporosis and fractures, hence being cautious during prolonged usage is necessary. Hypomagnesemia may rarely occur, so patients taking this medication long-term or in conjunction with certain drugs should regularly check magnesium levels. As this medication strongly suppresses gastric acid secretion, there is a slightly increased risk of gastrointestinal bacterial infections. Particularly, if diarrhea persists for a long time, consult a doctor. Caution is necessary while driving or operating machinery as drowsiness may occur. There may be interactions with other medications, so especially if taking antibiotics, anticoagulants, or antiviral drugs, it is essential to inform a doctor. This medication should not be chewed or crushed, but taken whole in tablet form, and stored out of reach of children. In case of overdose, there is no specific antidote, but appropriate treatment should be provided based on symptoms, as the medication is not easily dialyzable. Finally, long-term use of this medication may lead to vitamin B12 absorption disorders, so monitoring of this is necessary during prolonged usage.

Side effects

Rash, urticaria, itching, erythrocytopenia, leukopenia, leukocytosis, eosinophilia, neutrophilia, lymphopenia, anemia, purpura, lymphadenopathy, hypochromic anemia, pancytopenia, agranulocytosis, thrombocytopenia, hemolytic anemia, elevated ALT, elevated AST, elevated ALP, elevated γ-GTP, elevated LDH, elevated total bilirubin, fulminant hepatitis, liver dysfunction, jaundice, hypertension, myocardial infarction, abnormal electrocardiogram, migraine, syncope, angina pectoris, heart block, palpitations, tachycardia, bradycardia, pulmonary embolism, ventricular tachycardia, thrombophlebitis, vasodilation, prolonged QTc, ventricular tachycardia, diarrhea, constipation, abdominal pain, abdominal distension, dyspepsia, belching, nausea, rectal bleeding, bloody stools, anorexia, cholelithiasis, oral ulcer, dysphagia, gingivitis, cholecystitis, increased appetite, abnormal stools, colitis, esophagitis, glossitis, pancreatitis, proctitis, thirst, vomiting, lower abdominal pain, gastric body, gastritis, stomatitis, altered taste sensation, hemorrhagic diarrhea, cholangitis, duodenitis, gastrointestinal bleeding, hepatic encephalopathy, hepatitis, liver cancer, hepatic steatosis, sialadenitis, thirst, headache, insomnia, anxiety, dizziness, convulsions, abnormal dreams, decreased libido, neuropathy, paresthesia, tremors, weakness, hyperesthesia, drowsiness, vertigo, depression, agitation, amnesia, confusion, extrapyramidal syndrome, hypervolemia, limb weakness, sensory neuropathy, decreased grip strength, language confusion, staggering, delirium, disorientation, hypersomnia, cough, pharyngitis, rhinitis, shortness of breath, asthma, epistaxis, laryngitis, hiccups, hyperventilation, bronchitis, sinusitis, apnea, respiratory depression, interstitial pneumonia, myalgia, back pain, arthritis, leg cramps, bone pain, arthropathy, bursitis, hypertonicity, neuralgia, focal muscle contraction, sweating, alopecia, dry skin, shingles, psoriasis, skin pigmentation changes, toxic epidermal necrolysis, mucous membrane syndrome, erythema multiforme, cataract, amblyopia, glaucoma, dry eyes, abnormal vision, tinnitus, otitis media, corneal opacity, blurred vision, double vision, hearing loss, eye pain, retinal degeneration, strabismus, proteinuria, cystitis, frequent urination, dysmenorrhea, dysuria, nephrolithiasis, uterine bleeding, polyuria, gynecomastia, hematuria, erectile dysfunction, vaginal discharge, menorrhagia, orchitis, incontinence, interstitial nephritis, edema, elevated total cholesterol, elevated triglycerides, elevated BUN, elevated serum thyroid-stimulating hormone, chest pain, chills, fever, urinary tract infection, erythema, fatigue, weight gain, visual disturbances, anorexia, neck stiffness, photophobic reaction, hangover effect, weight loss, gout, anaphylaxis, shock, hepatitis, jaundice, hepatic encephalopathy, sudden death, coma, hyperammonemia, rhabdomyolysis, disorientation, delirium, angioedema, hypomagnesemia, thrombocytopenia, neutropenia, agranulocytosis, hemolytic anemia, pancytopenia, vesicular skin rash, urticarial skin rash, systemic allergic reaction, myalgia, arthralgia, interstitial nephritis, gynecomastia, interstitial pneumonia, elevated thyroid-stimulating hormone, erythema multiforme, toxic epidermal necrolysis, mucous membrane syndrome, Clostridium difficile-associated diarrhea, systemic lupus erythematosus, lupus erythematosus of the skin

Not everyone experiences these, and they can vary from person to person.

Storage

This medication can be sensitive to air and moisture, so it must be stored in a tightly closed container. It is important to maintain a storage temperature between 1 to 30 degrees Celsius. Proper storage will ensure the medication's effectiveness.

Appearance and packaging

Appearance

Pale yellow round enteric coated tablets

Package unit

28 tablets (14 tablets / PTP*2)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.